Floatz logo

COCARBOXYLASE

Neuropathic Pain

Egyptian International Pharmaceutical Industries CoSmall moleculePhase 4 / ApprovedActive
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
73/ 100

Competitive context

55 Active assets in the Neuropathic Pain cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Ataturk University
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Margaux M. Salas, PhD
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Medipol University
Phase 4BBB
Nabilone
Eldon Loh, MD
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of British Columbia
Phase 4BB

View all 50 →

Same molecule, other indications

COCARBOXYLASE is also rated in:

Alzheimer's DiseaseDormant
CCC
Indicative ·
54 / 100
View asset →
HyperbilirubinemiaDormant
CCC
Indicative ·
53 / 100
View asset →
Acute Lymphoblastic LeukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →